Axogen, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US05463X1063
USD
44.84
0.27 (0.61%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sanara MedTech, Inc.
NeuroPace, Inc.
ZimVie, Inc.
Anika Therapeutics, Inc.
Axogen, Inc.
Standard BioTools, Inc.
AVITA Medical, Inc.
Allurion Technologies, Inc.
Accuray, Inc.
Pulse Biosciences, Inc.
Alpha Tau Medical Ltd.

Why is Axogen, Inc. ?

1
Poor long term growth as Operating profit has grown by an annual rate 10.69% of over the last 5 years
2
Flat results in Mar 26
  • NET PROFIT(HY) At USD -13.81 MM has Grown at -322.16%
  • EPS(Q) Lowest at USD -0.38
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 382.67%, its profits have fallen by -34.1%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Axogen, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Axogen, Inc.
382.67%
9.96
54.28%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
14.93%
EBIT Growth (5y)
10.69%
EBIT to Interest (avg)
-13.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
1.20
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.71%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
12.60
EV to EBIT
-207.49
EV to EBITDA
1628.59
EV to Capital Employed
12.15
EV to Sales
7.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.85%
ROE (Latest)
-10.98%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 15.55 MM

DEBT-EQUITY RATIO (HY)

Lowest at -33.89 %

DEBTORS TURNOVER RATIO(HY)

Highest at 8.72 times

RAW MATERIAL COST(Y)

Fallen by -4.54% (YoY

NET SALES(Q)

Highest at USD 61.46 MM

-9What is not working for the Company
NET PROFIT(HY)

At USD -13.81 MM has Grown at -322.16%

EPS(Q)

Lowest at USD -0.38

Here's what is working for Axogen, Inc.

Operating Cash Flow
Highest at USD 15.55 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at -33.89 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 8.72 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
Highest at USD 61.46 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Raw Material Cost
Fallen by -4.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Axogen, Inc.

Net Profit
At USD -13.81 MM has Grown at -322.16%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

EPS
Lowest at USD -0.38
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)